Prof. Deepak Kaul
( Academic Profile)
A.
ACADEMIC QUALIFICATIONS
:
Ph.D (AIIMS), FICA , FNA
B.
PRESENT APPOINTMENT
:
Professor & Head
Deptt. of Expt. Medicine &
Biotechnology
PGIMER, Chandigarh-160012
C.
RESEARCH SPECIALIZATION
:
Molecular Pathology


E.
Functional Genomics
Genomic-Immunity
AWARDS & HONOURS
 Fellow, Indian National Science Academy (FNA)


Fellow, International College of Angiology, USA
Member, American Association of Advancement of Science
 Member, New York Academy of Sciences
 Moscow University Medal awarded by Cardiology Research Centre, USSR.
F.
EDITORIAL BOARD (International)
I. Member, “ Editorial Board”,
 Journal of Antivirals & Antiretrovirals
 Word Journal Of Cardiology
 AsianJournal Of Medical Sciences
II. Member, “ Editorial-Review Board”




International Journal of Cardiology.
Leukemia Research.
Archives of Biochemistry & Biophysics.
Molecular & Cellular Biochemistry
G.
H.
NATIONAL COMMITMENTS

President (Ex), Indian Society of Atherosclerosis Research

Chairman, Leukemia Research Foundation, India

Member, Advisory Board , U.P.S.C , Govt. Of India

Member, Advisory Committee INSA Awards.

Member, INSA Selection Committee for Medical Sciences.

Member, Advisory IND Committee, Drugs Controller- General (India).

Member, Selection Committee Commonwealth Fellowships (2009-10).

Member, Medical Biotechnology & Nanotechnology committee, Bureau
of Indian Standards, New Delhi-110002.

Member , Society For Scientific Values (India).

Governing Council
Development, India

Member, Task-Force on RNA-Interference, Deptt. Of Biotechnology,
Ministry of Science & Technology , Govt. Of India.

Member, Board of studies in Human Genomics and Pharmaceutical
Sciences, Punjab University, Chandigarh.

Member , Faculty Selection Committee , All India Institute Of Medical
Sciences , New Delhi.

Ph.D Thesis Examiner : Sree Chitra Tirunal Institute For Medical
Sciences & Technology , Thiruvananthapuram (Kerala). Sanjay Gandhi
Post Graduate Institute of Medical Sciences, Lucknow. All India Institute
Of Medical Sciences; New Delhi
Member,
Idma
THESIS GUIDED (AS CHIEF GUIDE)


Ph.D. (Molecular Medicine)
M.Sc. (Medical Biotechnology)
= 14
= 6
Foundation
of
Sustainable
EXTRA MURAL RESEARCH GRANTS
I.
Sr.
No.
National Funding
Agency
1.
2.
3.
4.
5.
6.
J.
ICMR
CSIR
DAE
DST
INDO-USA (DBT)
DBT
ON-GOING
RESEARCH
PROJECTS
3
1
PUBLICATIONS
International
 National
 Conference Presentations
 Conference Chaired

K.
RESEARCH
PROJECTS
COMPLETED
14
9
1
3
1
3
=
88
=
=
28
86
=
25
TOTAL = 116
INTERNATIONAL CITATION
Times Cited

Am. J. Hypertension
21

Atherosclerosis
17

J. Lipid Research
18

Pharmacol. & Therapeutics
13

J. Biol. Chemistry
19

Circulation Research
24

Nutrition Metabolin & Cardiovasc. Disease
5

Arteriosc. Thombosis & Vasc. Biology
56

Int. J. Parasitology
3

Biochem. J.
1

J. Infection
1

Parasite Immunol.
1

Proc. Natl. Acad. Sci. (USA)
15

Microbiol. & Mol. Biol. Rev.
8
L.
List of Publications in Molecular Pathology
… Dr. Deepak Kaul
L1.
1.
International
D. KAUL, M.G. Karmarker and V. Kothekar (1978) : Chemical constitution
of lipid droplets in human atherosclerotic lesion, Artery, 4, 497-503.
2.
D. KAUL, V. Kotherkar and R.K. Mishra (1980) : Micellar organisation of
lipid droplets in human atherosclerotic lesions. Atherosclerosis, 37, 139142.
3.
S.K. Bansal and D. KAUL (1981) : Mesomorphic state of lipid in biliary
canaliculi. Med. Sci. Biochem., 9, 488-489.
4.
D. KAUL (1981) : Atherogenesis : Structure of Pathomorphic lipid
droplets. Atherosclerosis, 40, 223-230.
5.
D. KAUL (1983) : Atherosclerosis : A molecular disease of membrane
fusion. Medical Hypothesis, 11, 439-447.
6.
D. KAUL (1983) : Fusion Process : Significance of free cholestrol to
phospholipid ratio within membrane. Med. Sci. Biochem., 11, 254-255.
7.
D. KAUL and M.G. Karmarkar (1983) : Molecular mechanism involved in
cellular membrance fusion. Med. Sci. Biochem., 11, 556-557.
8.
D. KAUL and N. Munjunath (1983) : Role of membrane cholestrol in
process of somatic cell hybridisation. Med. Sci. Biochem., 11, 596-597.
9.
D. KAUL (1986) : Role of calcium, cyclic AMP in cholesterol-rich human
platelet activity. Med. Sci. Biochem., 14, 238-239.
10.
A.
Saxena,
D.
KAUL
and
V.K.
Vinayak
(1986)
:
Amoebic
erythrophagocytosis. Significance of membrane cholestrol to phospholipid
ratio. Med. Sci. Biochem., 14, 330-331.
D. KAUL and R.S. Kukreja (1987) : Atherogenesis : Preventive effect of
Trifluoperazine Atherosclerosis, 64, , 211-214
12.
S. Jain, D. KAUL and V.K. Vinayak (1987) : Elucidation of the receptors in
Macrophage and plasmodium Yoeli interactions. Immunol. Invest. 11,
179-187.
13.
D. KAUL (1988) : Calcium antagonists : A new preventive approach to
atherogenesis. Proc. of symposium of heart disease, U.S.S.R. Acad. Med.
Sci. held at Moscow.
14.
Uma Mehta and D. KAUL (1990) : Effect of Trifluoperazine on DNA and
LDL
receptor
synthesis
in
smooth
muscle
cells
exposed
to
hypercholesterolemic medium in vitro. Biochem. Med. Metab. Biol. 43,
175-181.
15.
Uma Mehta and D. KAUL (1990) : Effect of trifluoperazine and colchicine
on smooth muscle cellular proliferation and collagen secretion induced by
hypercholesterolemic medium in vitro. Biochem. Int. 21, 107-116.
16.
Uma Mehta , R.S. Kukreja and D. KAUL (1990) : Effect of Colchicine on
cholesterol
metabolism
of
smooth
muscle
cells
exposed
hypercholesterolemic medium in vitro, Med. Sci. Res. 18, 365-367.
to
17.
Uma Mehta and D. KAUL (1990) : Effect of Trifuoperazine on cholestrol
metabolism of smooth muscle cells exposed to hypercholesterolemic
medium in vitro. Biochem. Med. Metabl. Biol. 44, 151-158.
18.
D. KAUL and Uma Mehta (1990) : Membrane-cholesterol modulates the
atherogenic activity of smooth muscle cells in vitro. Med. Sci. Res. 18,
717-720.
19.
Uma Mehta and D. KAUL (1991) : Nature of aortic smooth muscle cellular
activity
induced
by
cholesterol-incorporation
through
LDL-receptor
independent pathway. Preventive role of Trifluoperazine on such activity.
Exp. Mol. Pathol. 55, 13-24.
20.
D. KAUL, V. Diwan and U. Mehta (1991) : Nature of interrelationship
between cholesterogenesis and DNA replication within smooth muscle
cells stimulated by cholesterol in vitro. Med. Sci. Res. 19, 337-343.
21.
A. Mohindroo, R.S. Kukreja, R.N. Chakravarti, N.K. Ganguly and D. KAUL
(1981) : Effectiveness of Trifluoperazine against cholesterol induced
atherosclerosis in rhesus monkey. Med. Sci. Res. 19, 341-343.
22.
N. Kochhar and D. KAUL (1992) : Molecular link between membrane
cholesterol and Na+/H+ exchange within human platelets. FEBS Lett.
299, 19-22.
23.
N. Kochhar and D. KAUL (1992) : Molecular link between membranecholesterol and cyclic nucleotide levels within human platelets. Blood
coagulation and Fibrinolysis, 3, 251-219.
24.
N.Kochhar and D. KAUL (1992) : Initiator-promotor coupling of
phospholipase ‘D’ and ‘A2’ in platelets upon cholesterol-incorporation.
FEBS Lett. 314, 17-19.
25.
D. KAUL and Jarnail Singh (1994) : Exogenous cholesterol initiated
transmembrane signalling pathway regulates cholesterogenesis in human
platelets. Cell Signall, 6, 141-145.
26.
J. Singh and D. KAUL (1994) : Autoregulation of receptor-S at the
translation level in human platelets. Atherosclerosis, 109, 1090.
27.
N. Kochhar and D. KAUL (1994) : Molecular mechanism involved in
cholestrol modulated human platelet activity. Atherosclerosis, 109, 196a.
28.
D. KAUL (1995) : Lipoprotein Receptor - ‘Ck’ activation-response coupling
in human platelets. Platelet, 6, 306-309.
29.
D. KAUL, N. Kochar and J. Singh (1995) : Lipoprotein Receptor- ‘Ck’
dependent signalling in human platelets. Mol. Cellul. Biochem., 151, 173176.
30.
D. KAUL, V. Dhawan and M. Kaur (1996) : Evidence and nature of a
novel thiol-oxidase in human platelets. Mol. Cellul. Biochem., 159, 81-84.
31.
R. Goel, D. KAUL and S. Varma (1996) : Lymphocytes from CML patients
lack 47 kDa factor having affinity for genomic sterol regulatory sequence.
Leukemia Res., 20, 877-879.
32.
R. Goel, S.Varma and D. KAUL (1996) : Sterol-dependent LDL-Receptor
gene transcription in lymphocytes from normal and CML patients. Cancer
Lett., 107, 193-198.
33.
D. KAUL and J. Singh (1997) : Does Receptor-‘Ck’ deficiency initiate
Leukemia ? Cancer Lett., 112, 199-202.
34.
R. Goel , J. Singh and D. KAUL (1997) : Receptor-‘Ck’ dependent
signalling regulated LDL-receptor gene transcription. Mol. Cellul.
Biochem., 169, 79-83.
35.
D. KAUL and M. Kaur (1997) : LDL-dependent regulation of Bcl-2 and
Cyclin ‘D’ Gene expression in lymphocytes from normal and CML patients.
Cancer Lett., 119, 131-135.
36.
J. Singh and D. KAUL (1997) : RNA-mediated regulation of Receptor-‘Ck’
gene in human platelets. Mol. Cellul. Biochem., 173, 189-192.
37.
M. Kaur, and D. KAUL (1997) : Mevalonate Pathway-dependent
regulation of cell cycle. FASEB, J. 11, 2103a.
38.
J. Singh and D. KAUL (1997) : Regulation of cholesterol-specific
Receptor-‘Ck’ gene at the translational level. FASEB, J. 11, 2185a.
39.
D. KAUL, M. Kaur, V. Dhawan (1998) : Human platelets contain a novel
47kDa
Thioloxidase
having
affinity
for
genomic
sterol-regulatory
sequence. Mol. Cellul. Biochem., 178, 383-385.
40.
D. KAUL and M. Kaur (1998) : Receptor-‘Ck’ controls the expression of
Bcl-2 and cyclin ‘D’ genes. Leukemia Res. 22, 671-675.
41.
D. KAUL and M. Kaur (1998) : Receptor-‘Ck’ dependent regulation of gene
in HL-60 cell line. Leukemia Res., 21, 11-12.
42.
J. Singh, M. Kaur and D. KAUL (1998) : RNA-mediated regulation of Bcl-2
and cyclin ‘D’ genes in human platelets. Platelets, 9, 37-40.
43.
R. Goel and D. KAUL (1998) : Molecular control of LDL-Receptor gene in
leukemic cells. Leukemia Res., 22, 89-92.
44.
M. Kaur, D. KAUL and R.C. Sobti (1998) : Receptor-‘Ck’ dependent
regulation of genes involved in the cell cycle. Mol. Cellul. Biochem. 181,
137-142.
45.
D. KAUL (1998) : Receptor-‘Ck’ and Leukemogenesis. Leukemia Res.,
22, 389-394.
46.
A. Wanchu and D. KAUL (1998) : Antibodies against Receptor-Ck are
found in patients
with systemic lupus Erythematosis (SLE). Proc.
International Congress on Immunology held Nov.1-6, New Delhi.
47.
D. KAUL and N. Varma (1999) : Molecular mechanism involved in TPAinduced myelopoietic programming. Leukemia Res., 23, 235-237.
48.
D. KAUL and M. Kaur (1999) : Receptor-Ck regulates the expression of
cyclin-dependent
Kinase inhibitors Mol. Cellul. Biochem, 200, 183-
186.
49.
D. KAUL and N. Varma (2000) : Expression of Receptor-Ck and SREBP
genes in lymphocytes from acute leukemia patients. Leukemia Res. 24,
913-916.
50.
A. Wanchu, P. Bambery, A. Sud and D. KAUL (2000) : Antibodies against
Receptor-Ck in patients with systemic lupus Erythematosis APLAR. J.
Rheumatology. 4, 14-16.
51.
D. KAUL (2001) : Molecular link between cholesterol, cytokines and
Atherogenesis. Mol. Cellul. Biochem. 219, 65-71.
52.
D. KAUL and M. Kaur (2001) : Receptor-Ck regulates membrane-bound
125 kDa protein having affinity for Genomic sterol regulatory sequence.
Mol. Cellul. Biochem. 216, 141-143.
53.
U. Trehan, G. Garewal, D. KAUL, R. Das (2001) : Molecular Pathology of
Alpha-Thalassemia and Triplicated Alpha locus in north Indian population
– Interaction with heterozygous Beta-Thalassemia. Hematology, 6, 153160.
54.
D. KAUL, R. Rani and R. Sehgal (2001) : Receptor-Ck regulates Giardia
encystation process. Mol Cellul. Biochem. 225, 167-169.
55.
D. KAUL and P.K. Anand (2003) : Regulation of PPAR- gene in human
promyelocytic HL-60 cells line : Leukemic Res 27, 683-686.
56.
D. KAUL (2003): Cholesterol-Receptor mediated genomics in health and
disease. Trends in Mol. Medicine 9, 442-449.
57.
P.K. Anand and D. KAUL (2003) : Vitamin D3-dependent pathway
regulates TACO gene transcription. Biochem. Biophys. Res. Commun.,
310, 876-877.
59.
D. KAUL, K. Sikand and A.R,Shukla(2004) : Effect of Green Tea-desired
polyphenols on the genomics of Atherosclerosis. Phytotherapy Research
18, 177-179.
60.
D. KAUL, P.K. Anand and I. Verma (2004) : Cholesterol sensor initiates
M. Tuberculosis entry into human macrophages. Mol. Cellul. Biochem.
258, 219-222.
61.
D. KAUL and K. Sikand (2004): Defective RNA-mediated c-myc gene
silencing pathway
in Burkitt’s lymphoma. Biochem. Biophys. Res.
Commun. 313, 552-554.
62.
K. Sikand and D. KAUL (2004) : A novel genetic aberration in Burkitt’s
lymphoma cell line. Int. J. Cancer Prevention, 1, 355-360.
63.
D. KAUL and Iqbal M. Baba (2005): Genomic effect of vitamin ‘C’ and
statins within human mononuclear cells involved in atherogenic process.
Eur. J. Clin. Nutrition 59, 978- 981.
64.
P. Anand and D. KAUL (2005): Down-regulation of TACO gene
transcription restricts Mycobacterium tuberculosis entry/survival within
macrophages. FEMS Microbiol. Lett. 250, 137-144
65.
D. KAUL, A.R. Shukla, K.Sikand and V. Dhawan (2005) : Effect of herbal
polyphenols on atherogenic transcriptome. Mol.Cellul. Biochem., 278,
177-184.
66.
M. Iqbal Baba, D. KAUL and A. Grover (2006): Importance of blood
cellular genomic
profile in coronary heart disease. J. BIomed. Sci. 13,
17-26.
67.
K. Sikand, D. KAUL and N. Varma (2006): Receptor Ck dependent
signaling regulates hTERT gene transcription. BMC Cell Biology 7, 222.
68.
P.K. Anand, D. KAUL and M. Sharma (2006): EGCG inhibits M.
tuberculosis survival through down-regulation of TACO gene within human
macrophages. Int. J. Biochem. Cell Biology, 38, 600-609.
69.
M. Iqbal Baba, D. KAUL and A. Grover (2006): Pathognomic genetic
expression profile within peripheral blood mononuclear cells of rheumatic
heart disease patients. Mol. Cellul. Biochem. 291, 213-217.
70.
D. KAUL, P.K. Anand and A. Khanna (2006): Functional genomics of
PPAR- gene in
human immunomodulatory cells. Mol. Cell. Biochem.
290, 211-215.
71.
D. KAUL, A. Gautam and K. Sikand (2006) : Importance of LxR-
transcriptome in the modulation of innate immunity. Mol. Cellul. Biochem.
292, 53-57.
72. D. KAUL and A. Mehrotra (2007) : Functional charactisation of AATF
transcriptome in
human leukemic cells. Mol. Cell. Biochem. 297, 215-
220.
73.
D. KAUL and A. Khanna (2007) : AATF (Apotosis Antagonizing
Transcription Factor). Atlas Genet. Cytogenet. Oncol. Haematol. URL :
http://Atlas Genetics Oncology.org/Genes/AATFID534ch17q11.html
74.
P. K. Anand, D.KAUL and M. Sharma (2008): Synergistic action of vitamin
D and retinoic acid restricts invasion of pathogenic mycobacteria into
macrophages. J. Microbiol. Immunology Infection, , 41,7-25 .
75.
D. KAUL (2008) : Coronin-1A epigenomics governs mycobacterial
persistence in tuberculosis. FEMS Microbiol. Lett. 278; 10-14.
76.
D. KAUL, A. GAUTUM, S. Varma and A. Ahlawat (2008) : Functional
genomics of hTERT gene in leukemic myelopoiesis. Mol. Cell. Biochem.
314, 19-23.
77.
V.P. DAVE, D. KAUL, V. Sharma and Bhattacharya R. (2009) : Functional
genomics of blood cellular LxR-α gene in human Coronary disease. J.
Mol. Cell. Cardiol. 46, 536-544.
78.
D. KAUL, A.Ahlawat and S.DuttaGupta (2009): HIV-1 genome-encoded
hiv1-mir-H1 impairs responces to infection.Mol.Cell.Biochem,323 ,143148.
79.
N Mahajan, V Dhawan, G Sharma, S Jain, D. KAUL (2008). Effect of
green tea polyphenols on inflammation and vascular remodelling in
normocholsterolemic virgin hypertensives. J Hum Hypertension 22, 141143.
80.
N Mallik, V Dhawan, A Bahl, D KAUL (2009). Inhibitory effects of
Terminalia arjuna on platelet activation in vitro in healthy subjects and
patients with coronary artery disease. Platelets. 4, 1-8.
81.
R.Kumar, D.Prasad, D.Kaul, A.Kanwar (2010). Liver-X receptor expression
in human malnocyetes, does it have a role in the pathogenesis of Vitiligo?
Experimental Dermatology 19, 62-64.
81.
A.Mehrotra, K.Joshi, D.Kaul (2010). E2F-1 Rnomics is critical for
reprogramming of cancer cells to quiescent state. Int. Journal of
cancer 127, 849-58.
83.
D.Banerjee,
D.Kaul
(2010).
Combined
inhalational
and
oral
supplementation of ascorbic acid may prevent influenza pandemic
emergency: a hypothesis. Nutrition 26, 128-32.
84.
D.S. Gupta, D.Kaul, A.J.Kanwar, D.Prasad (2010). Psoriasis: crucial role
of LXR-a RNomics. Genes Immun. 11, 37-44.
85.
A.Raina ,D. Kaul (2010). LXR-α genomics programmes neuronal death
observed in Alzheimer's disease. Apoptosis 15, 1461-1469.
86.
S.Bhatia ,D. Kaul , N.Varma (2010). Potential tumor suppressive function of
miR-196b in B-cell lineage acute lymphoblastic leukemia.
Mol.Cell.Biochem 340, 97-106.
87.
Bhatia S, Kaul D, Varma N (2011). Functional genomics of tumor
suppressor miR-196b in T-cell acute lymphoblastic leukemia.
Mol.Cell.Biochem 346, 103-116.
88.
Mehrotra A, Kaul D, Joshi K.(2011). LXR-α selectively reprogrammes
cancer cells to enter into apoptosis. Mol.Cell.Biochem (in press)
L2.
89.
NATIONAL
D. KAUL (1984) : Molecular mechanism involved in cholesterol induced
atherogenesis. Bull PGI, 18, 101-106.
90.
D. KAUL, R.S. Kukreja and R.P. Sapru (1987) : Effect of trifuloperazine on
the prevention of atherosclerosis in rabbits. Ind. J. Med. Res. 86, 678683.
91.
A. Mohindroo, R.S. Kukreja and D. KAUL (1989) : Preventive effect of
trifluoperazine on atherosclerosis induced by cholesterol and adrenaline in
rabbits. Ind. J. Med. Res. 90, 215-219.
92.
Uma Mehta and D. KAUL (1990) : Effect of antitubulin and anticalmodulin
on LDL-receptors in smooth muscle cells exposed to hypercholesterolemic
medium in vitro. Ind. J. Biochem. Biophys. 27, 251-253.
93.
D. KAUL (1982) : Membrane-fusion and Atherosclerosis : Proc. WHOAIIMS workshop on lipids and lipoproteins in health and disease held on
22nd-23rd Nov. at AIIMS, New Delhi.
94.
D. KAUL (1990) : Aortic explant culture of smooth muscle cells as a model
for studying cholesterol induced atherogenesi in vitro. Current trends in
atherosclerosis Research-edited by Dr. (Mrs.) M. Madhavan, Madras
(India).
95.
D. KAUL (1991) : LDL-receptor independent pathway bloker : a novel
approach in the prevention of cholesterol-induced atherogenesis, Proc. Of
National sysmposium of “Prevention of Heart Disease” edited by Dr.
Subramanyam, Tirupti (India).
96.
D. KAUL (1993) : Do human platelets posses LDL-receptor specific for
Aporprotein ‘B’ or cholesterol ? Current Science, 65, 883-886.
97.
D. KAUL (1993) : Does cross talk between Receptor-transmitter
molecules define gene regulatory code? Prcoeedings of the Chandigarh
Symposium on New Biology, 5-6 Dec., 1993.
98.
Uma Mehta, R.S. Kukreja and D. KAUL (1994) : Effect of colchicine on
atherogenic
activity
of
smooth
muscle
cells
exposed
hypercholesterolemic medium in vitro. Proc. Natl. Acad. Sci. 64, 79-90.
to
99.
A. Gupta, U. Mehta, R.S. Kukreja and D. KAUL (1995) : Transcriptional
expression of LDL-receptor gene in aortic atherosclerotic lesions induced
by cholesterol-rich diet. Curr. Science, 68, 1124-1125.
100.
A. Gupta and D. KAUL (1995) : Atherogenesis : Role of protooncogenes.
Bull. PGI, 29,
60-63.
101.
D. KAUL (1996) : Role of Biotechnology in health care. Bull. PGI. 30, 1-3.
102.
A. Wanchu, S.D. Deodhar, P. Mambery, A. Sud and D. KAUL (1996) :
Lack of expression of c-myc oncogene in peripheral blood mononuclear
cells of patients with active rheumatoid arthritis. Ind. J. Med. Res. 104,
223-225.
103.
Akshay Anand, S. Prabhakar and D. KAUL (1998) : Molecular Diagnosis
of DMD/BMD patients. Neurology India, 46, 256-260.
104.
D. KAUL and M. Kaur (1999) : Receptor-Ck controls cholesterogenesis
and DNA replication in HepG2 cells. Current Science, 77, 592-594.
105.
Akshay Anand, S. Prabhakar and D. KAUL (1999) : Genetic
Polymorphism in muscle biopsies from DMD/BMD patients, Neurology
India, 47, 218-223.
106.
D. KAUL and V.K. Khosla (2000) : Molecular basis of “cholesterol feed
back lesion” in CNS Tumors. Neurology India, 48, 174-177.
107.
D. KAUL and Joginder Singh (2001) : Leukemia Inhibitory factor in human
milk. Curr. Science, 80, 737.
108.
D. Tyagi, B.S. Sharma, D. KAUL, R.K. Vashisth, S.K. Gupta and V.K.
Khosla (2002) : Expression of Bcl-2 protooncogene in primary tumors of
central nervous system. Neurology India, 50, 290-294 .
109.
P.K. Anand and D. KAUL (2002) : Oxysterol receptor LxR regulates
SREBP gene expression in the HL-60 cells exposed to differentiating
agents. Curr. Science, 82, 136-137.
110.
D. KAUL and J.S. Verma (2002) : Expression and functional activity of
Receptor-Ck in Mononuclear cells of Homozygous Hypercholesterolemic
(HFH) family. Ind. Heart Journal, 54, 88-90.
111.
D. KAUL (2002): Functional genomics of Receptor Ck in developmental
stages of human atherosclerotic arterial wall. Proc. XV Annual
Conference of I.S.A.R. held in Tirupati.
112.
D. KAUL and P.K. Anand (2003) : Receptor-Ck regulates HMGCoA
reductase gene in HL-60 cells. Curr. Science 85, 643-645.
113.
D. KAUL, R. Kaur, I. Baba and D. Singh (2003) : Functional proteomics of
Receptor-Ck in developmental stages of human atherosclerotic arterial
wall. Ind. Heart Journal, 55, 252-254.
114.
D. KAUL and A. Khanna (2006): Evidence and nature of a novel miRNA
encoded by HIV-1. Proc. Ind. Natl. Acad. Sci. 72, 91-95.
115.
D. KAUL (2007) : Cellular AATF gene : Armour against HIV-1. Ind. J.
Biochem. Biophys. 44 , 276-278.
116.
D.KAUL and A.Hussain (2009) : Cellular AATF gene encodes a novel
miRNA that
can
contribute
Biophys. 46 , 237-240.
to HIV-1 Latency. Ind. J. Biochem.